These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 28515464)

  • 21. Diabetes and Tuberculosis.
    Restrepo BI
    Microbiol Spectr; 2016 Dec; 4(6):. PubMed ID: 28084206
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence for a More Disrupted Immune-Endocrine Relation and Cortisol Immunologic Influences in the Context of Tuberculosis and Type 2 Diabetes Comorbidity.
    Fernández RDV; Díaz A; Bongiovanni B; Gallucci G; Bértola D; Gardeñez W; Lioi S; Bertolin Y; Galliano R; Bay ML; Bottasso O; D'Attilio L
    Front Endocrinol (Lausanne); 2020; 11():126. PubMed ID: 32265833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TB-diabetes co-morbidity in Ghana: The importance of Mycobacterium africanum infection.
    Asante-Poku A; Asare P; Baddoo NA; Forson A; Klevor P; Otchere ID; Aboagye SY; Osei-Wusu S; Danso EK; Koram K; Gagneux S; Yeboah-Manu D
    PLoS One; 2019; 14(2):e0211822. PubMed ID: 30730937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impaired resolution of blood transcriptomes through tuberculosis treatment with diabetes comorbidity.
    Eckold C; van Doorn CLR; Ruslami R; Ronacher K; Riza AL; van Veen S; Lee JS; Kumar V; Kerry-Barnard S; Malherbe ST; Kleynhans L; Stanley K; Joosten SA; Critchley JA; Hill PC; van Crevel R; Wijmenga C; Haks MC; Ioana M; Alisjahbana B; Walzl G; Ottenhoff THM; Dockrell HM; Vianello E; Cliff JM;
    Clin Transl Med; 2023 Sep; 13(9):e1375. PubMed ID: 37649224
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma Eicosanoid Levels in Tuberculosis and Tuberculosis-Diabetes Co-morbidity Are Associated With Lung Pathology and Bacterial Burden.
    Pavan Kumar N; Moideen K; Nancy A; Viswanathan V; Shruthi BS; Shanmugam S; Hissar S; Kornfeld H; Babu S
    Front Cell Infect Microbiol; 2019; 9():335. PubMed ID: 31632923
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diabetes and pulmonary tuberculosis: a global overview with special focus on the situation in Asian countries with high TB-DM burden.
    Zheng C; Hu M; Gao F
    Glob Health Action; 2017; 10(1):1-11. PubMed ID: 28245710
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunological Impacts of Diabetes on the Susceptibility of Mycobacterium tuberculosis.
    Ayelign B; Negash M; Genetu M; Wondmagegn T; Shibabaw T
    J Immunol Res; 2019; 2019():6196532. PubMed ID: 31583258
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tuberculosis-diabetes co-morbidity is characterized by heightened systemic levels of circulating angiogenic factors.
    Kumar NP; Moideen K; Sivakumar S; Menon PA; Viswanathan V; Kornfeld H; Babu S
    J Infect; 2017 Jan; 74(1):10-21. PubMed ID: 27717783
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Defining a Research Agenda to Address the Converging Epidemics of Tuberculosis and Diabetes: Part 1: Epidemiology and Clinical Management.
    Critchley JA; Restrepo BI; Ronacher K; Kapur A; Bremer AA; Schlesinger LS; Basaraba R; Kornfeld H; van Crevel R
    Chest; 2017 Jul; 152(1):165-173. PubMed ID: 28434936
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High Prevalence and Heterogeneity of Diabetes in Patients With TB in South India: A Report from the Effects of Diabetes on Tuberculosis Severity (EDOTS) Study.
    Kornfeld H; West K; Kane K; Kumpatla S; Zacharias RR; Martinez-Balzano C; Li W; Viswanathan V
    Chest; 2016 Jun; 149(6):1501-8. PubMed ID: 26973015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integrating TB and non-communicable diseases services: Pilot experience of screening for diabetes and hypertension in patients with Tuberculosis in Luanda, Angola.
    Segafredo G; Kapur A; Robbiati C; Joseph N; de Sousa JR; Putoto G; Manenti F; Atzori A; Fedeli U
    PLoS One; 2019; 14(7):e0218052. PubMed ID: 31276500
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diabetes mellitus and its associated factors among patients with tuberculosis attending directly observed treatment centres in Oyo State, Nigeria: a cross-sectional evaluation.
    Anyanwu MO; Ajumobi OO; Afolabi NB; Usman A; Kehinde A
    BMJ Open; 2022 Apr; 12(4):e059260. PubMed ID: 35365543
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk of active tuberculosis among people with diabetes mellitus: systematic review and meta-analysis.
    Hayashi S; Chandramohan D
    Trop Med Int Health; 2018 Oct; 23(10):1058-1070. PubMed ID: 30062731
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Common patterns and disease-related signatures in tuberculosis and sarcoidosis.
    Maertzdorf J; Weiner J; Mollenkopf HJ; ; Bauer T; Prasse A; Müller-Quernheim J; Kaufmann SH
    Proc Natl Acad Sci U S A; 2012 May; 109(20):7853-8. PubMed ID: 22547807
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detrimental association between diabetes and tuberculosis: An unresolved double trouble.
    Siddiqui AN; Hussain S; Siddiqui N; Khayyam KU; Tabrez S; Sharma M
    Diabetes Metab Syndr; 2018 Nov; 12(6):1101-1107. PubMed ID: 29802074
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How can tuberculosis services better support patients with a diabetes co-morbidity? A mixed methods study in the Philippines.
    Oliveira Hashiguchi L; Cox SE; Edwards T; Castro MC; Khan M; Liverani M
    BMC Health Serv Res; 2023 Sep; 23(1):1027. PubMed ID: 37749519
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of diabetes mellitus amongst hospitalized tuberculosis patients at an Indian tertiary care center: A descriptive analysis.
    Pande T; Huddart S; Xavier W; Kulavalli S; Chen T; Pai M; Saravu K
    PLoS One; 2018; 13(7):e0200838. PubMed ID: 30021016
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Profiling leucocyte subsets in tuberculosis-diabetes co-morbidity.
    Kumar NP; Moideen K; Dhakshinraj SD; Banurekha VV; Nair D; Dolla C; Kumaran P; Babu S
    Immunology; 2015 Oct; 146(2):243-50. PubMed ID: 26095067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The relation between diabetes mellitus and IFN-gamma, IL-12 and IL-10 productions by CD4+ alpha beta T cells and monocytes in patients with pulmonary tuberculosis].
    Tsukaguchi K; Okamura H; Ikuno M; Kobayashi A; Fukuoka A; Takenaka H; Yamamoto C; Tokuyama T; Okamoto Y; Fu A; Yoshikawa M; Yoneda T; Narita N
    Kekkaku; 1997 Nov; 72(11):617-22. PubMed ID: 9423299
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug resistance of previously treated tuberculosis patients with diabetes mellitus in Shandong, China.
    Song WM; Li YF; Liu JY; Tao NN; Liu Y; Zhang QY; Xu TT; Li SJ; An QQ; Liu SQ; Yu CB; Gao L; Yu CX; Zhang M; Li HC
    Respir Med; 2020 Mar; 163():105897. PubMed ID: 32056837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.